Copyright Reports & Markets. All rights reserved.

Global Cervical Cancer Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Cervical Cancer Market Overview

      • 1.1 Product Overview and Scope of Cervical Cancer
      • 1.2 Cervical Cancer Segment by Type
        • 1.2.1 Global Cervical Cancer Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Pap Testing
        • 1.2.3 HPV Testing
        • 1.2.4 Colposcopy
        • 1.2.5 Cervical Biopsies
      • 1.3 Cervical Cancer Segment by Application
        • 1.3.1 Cervical Cancer Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Cancer Palliative care clinics
        • 1.3.4 Diagnostic centers
        • 1.3.5 Pharmacies
      • 1.4 Global Cervical Cancer Market by Region
        • 1.4.1 Global Cervical Cancer Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Cervical Cancer Market Size
        • 1.5.1 Global Cervical Cancer Revenue (2014-2025)
        • 1.5.2 Global Cervical Cancer Production (2014-2025)

      2 Global Cervical Cancer Market Competition by Manufacturers

      • 2.1 Global Cervical Cancer Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Cervical Cancer Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Cervical Cancer Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Cervical Cancer Production Sites, Area Served, Product Types
      • 2.5 Cervical Cancer Market Competitive Situation and Trends
        • 2.5.1 Cervical Cancer Market Concentration Rate
        • 2.5.2 Cervical Cancer Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Cervical Cancer Production Market Share by Regions

      • 3.1 Global Cervical Cancer Production Market Share by Regions
      • 3.2 Global Cervical Cancer Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Cervical Cancer Production
        • 3.4.1 North America Cervical Cancer Production Growth Rate (2014-2019)
        • 3.4.2 North America Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Cervical Cancer Production
        • 3.5.1 Europe Cervical Cancer Production Growth Rate (2014-2019)
        • 3.5.2 Europe Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Cervical Cancer Production (2014-2019)
        • 3.6.1 China Cervical Cancer Production Growth Rate (2014-2019)
        • 3.6.2 China Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Cervical Cancer Production (2014-2019)
        • 3.7.1 Japan Cervical Cancer Production Growth Rate (2014-2019)
        • 3.7.2 Japan Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Cervical Cancer Consumption by Regions

      • 4.1 Global Cervical Cancer Consumption by Regions
      • 4.2 North America Cervical Cancer Consumption (2014-2019)
      • 4.3 Europe Cervical Cancer Consumption (2014-2019)
      • 4.4 China Cervical Cancer Consumption (2014-2019)
      • 4.5 Japan Cervical Cancer Consumption (2014-2019)

      5 Global Cervical Cancer Production, Revenue, Price Trend by Type

      • 5.1 Global Cervical Cancer Production Market Share by Type (2014-2019)
      • 5.2 Global Cervical Cancer Revenue Market Share by Type (2014-2019)
      • 5.3 Global Cervical Cancer Price by Type (2014-2019)
      • 5.4 Global Cervical Cancer Production Growth by Type (2014-2019)

      6 Global Cervical Cancer Market Analysis by Applications

      • 6.1 Global Cervical Cancer Consumption Market Share by Application (2014-2019)
      • 6.2 Global Cervical Cancer Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Cervical Cancer Business

      • 7.1 F. Hoffmann-La Roche
        • 7.1.1 F. Hoffmann-La Roche Cervical Cancer Production Sites and Area Served
        • 7.1.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.1.3 F. Hoffmann-La Roche Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 GlaxoSmithKline
        • 7.2.1 GlaxoSmithKline Cervical Cancer Production Sites and Area Served
        • 7.2.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.2.3 GlaxoSmithKline Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Merck
        • 7.3.1 Merck Cervical Cancer Production Sites and Area Served
        • 7.3.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.3.3 Merck Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Advaxis Immunotherapies
        • 7.4.1 Advaxis Immunotherapies Cervical Cancer Production Sites and Area Served
        • 7.4.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.4.3 Advaxis Immunotherapies Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Bionor Pharma
        • 7.5.1 Bionor Pharma Cervical Cancer Production Sites and Area Served
        • 7.5.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.5.3 Bionor Pharma Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Dendreon Corporation
        • 7.6.1 Dendreon Corporation Cervical Cancer Production Sites and Area Served
        • 7.6.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.6.3 Dendreon Corporation Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Inovio Pharmaceuticals
        • 7.7.1 Inovio Pharmaceuticals Cervical Cancer Production Sites and Area Served
        • 7.7.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.7.3 Inovio Pharmaceuticals Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 ISA Pharmaceuticals
        • 7.8.1 ISA Pharmaceuticals Cervical Cancer Production Sites and Area Served
        • 7.8.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.8.3 ISA Pharmaceuticals Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Otsuka Pharmaceuticals
        • 7.9.1 Otsuka Pharmaceuticals Cervical Cancer Production Sites and Area Served
        • 7.9.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.9.3 Otsuka Pharmaceuticals Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Profectus Biosciences
        • 7.10.1 Profectus Biosciences Cervical Cancer Production Sites and Area Served
        • 7.10.2 Cervical Cancer Product Introduction, Application and Specification
        • 7.10.3 Profectus Biosciences Cervical Cancer Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Virometix
      • 7.12 Hologic

      8 Cervical Cancer Manufacturing Cost Analysis

      • 8.1 Cervical Cancer Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Cervical Cancer
      • 8.4 Cervical Cancer Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Cervical Cancer Distributors List
      • 9.3 Cervical Cancer Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Cervical Cancer Market Forecast

      • 11.1 Global Cervical Cancer Production, Revenue Forecast
        • 11.1.1 Global Cervical Cancer Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Cervical Cancer Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Cervical Cancer Price and Trend Forecast (2019-2025)
      • 11.2 Global Cervical Cancer Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Cervical Cancer Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Cervical Cancer Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Cervical Cancer Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Cervical Cancer Production, Revenue Forecast (2019-2025)
      • 11.3 Global Cervical Cancer Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Cervical Cancer Consumption Forecast (2019-2025)
        • 11.3.2 Europe Cervical Cancer Consumption Forecast (2019-2025)
        • 11.3.3 China Cervical Cancer Consumption Forecast (2019-2025)
        • 11.3.4 Japan Cervical Cancer Consumption Forecast (2019-2025)
      • 11.4 Global Cervical Cancer Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Cervical Cancer Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.
        North America accounted for the largest share of the global market, followed by Europe. 
        Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region. 

        The global Cervical Cancer market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cervical Cancer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cervical Cancer market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        F. Hoffmann-La Roche
        GlaxoSmithKline
        Merck
        Advaxis Immunotherapies
        Bionor Pharma
        Dendreon Corporation
        Inovio Pharmaceuticals
        ISA Pharmaceuticals
        Otsuka Pharmaceuticals
        Profectus Biosciences
        Virometix
        Hologic

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Pap Testing
        HPV Testing
        Colposcopy
        Cervical Biopsies

        Segment by Application
        Hospitals
        Cancer Palliative care clinics
        Diagnostic centers
        Pharmacies

        Buy now